Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral nef and vpu proteins

Cell Reports

Volumn 10, Issue 4, 2015, Pages 586-599

  Sauter, Daniel ^a   Hotter, Dominik ^a   Van Driessche, Benoît ^b   Stürzel, Christina M ^a   Kluge, Silvia F ^a   Wildum, Steffen ^a   Yu, Hangxing ^a   Baumann, Bernd ^a   Wirth, Thomas ^a   Plantier, Jean Christophe ^c   Leoz, Marie ^c   Hahn, Beatrice H ^d   Van Lint, Carine ^b   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c Laboratoire Associé Au Centre National de Référence du VIH   (France)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; I KAPPA B; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEF PROTEIN; PROTEIN BETA TRCP; STRUCTURAL PROTEIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; VPU PROTEIN; I KAPPA B KINASE; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; INHIBITION KINETICS; INNATE IMMUNITY; ISG GENE; LIFE CYCLE STAGE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS ENTRY; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; GENE EXPRESSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; SIMIAE;

ANIMALS; GENE EXPRESSION; HIV-1; I-KAPPA B KINASE; I-KAPPA B PROTEINS; IMMUNITY, INNATE; LENTIVIRUSES, PRIMATE; NF-KAPPA B; VIRAL PROTEINS;

EID: 84922826976     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.12.047     Document Type: Article

References (53)

1. Akari H., Bour S., Kao S., Adachi A., Strebel K. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J.Exp. Med. 2001, 194:1299-1311.
2. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 1997, 3:1117-1123.
3. Bandres J.C., Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human Tcells invitro after T-cell receptor stimulation. J.Virol. 1994, 68:3243-3249.
4. Baumann B., Wagner M., Aleksic T., von Wichert G., Weber C.K., Adler G., Wirth T. Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis invivo. J.Clin. Invest. 2007, 117:1502-1513.
5. Bour S., Perrin C., Akari H., Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J.Biol. Chem. 2001, 276:15920-15928.
6. Chan J.K., Greene W.C. Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol. Rev. 2012, 246:286-310.
7. Coadou G., Gharbi-Benarous J., Megy S., Bertho G., Evrard-Todeschi N., Segeral E., Benarous R., Girault J.-P. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP. Biochemistry 2003, 42:14741-14751.
8. Cocka L.J., Bates P. Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog. 2012, 8:e1002931.
9. Doehle B.P., Chang K., Rustagi A., McNevin J., McElrath M.J., Gale M. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J.Virol. 2012, 86:8367-8374.
10. Douglas J.L., Viswanathan K., McCarroll M.N., Gustin J.K., Früh K., Moses A.V. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a betaTrCP-dependent mechanism. J.Virol. 2009, 83:7931-7947.
11. Felzien L.K., Woffendin C., Hottiger M.O., Subbramanian R.A., Cohen E.A., Nabel G.J. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. USA 1998, 95:5281-5286.
12. Fiume G., Vecchio E., De Laurentiis A., Trimboli F., Palmieri C., Pisano A., Falcone C., Pontoriero M., Rossi A., Scialdone A., et al. Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65. Nucleic Acids Res. 2012, 40:3548-3562.
13. Galão R.P., Le Tortorec A., Pickering S., Kueck T., Neil S.J.D. Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe 2012, 12:633-644.
14. Galão R.P., Pickering S., Curnock R., Neil S.J.D. Retroviral retention activates a Syk-dependent HemITAM in human tetherin. Cell Host Microbe 2014, 16:291-303.
15. Ghosh S., Hayden M.S. Celebrating 25 years of NF-κB research. Immunol. Rev. 2012, 246:5-13.
16. Girdlestone J., Isamat M., Gewert D., Milstein C. Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. Proc. Natl. Acad. Sci. USA 1993, 90:11568-11572.
17. Greenberg M.E., Bronson S., Lock M., Neumann M., Pavlakis G.N., Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 1997, 16:6964-6976.
18. Herbein G., Varin A., Larbi A., Fortin C., Mahlknecht U., Fulop T., Aggarwal B.B. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages. Curr. HIV Res. 2008, 6:117-129.
19. Hotter D., Kirchhoff F., Sauter D. HIV-1 Vpu does not degrade interferon regulatory factor 3. J.Virol. 2013, 87:7160-7165.
20. Jia B., Serra-Moreno R., Neidermyer W., Rahmberg A., Mackey J., Fofana I.B., Johnson W.E., Westmoreland S., Evans D.T. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog. 2009, 5:e1000429.
21. Kirchhoff F., Schindler M., Specht A., Arhel N., Münch J. Role of Nef in primate lentiviral immunopathogenesis. Cell. Mol. Life Sci. 2008, 65:2621-2636.
22. Kluge S.F., Mack K., Iyer S.S., Pujol F.M., Heigele A., Learn G.H., Usmani S.M., Sauter D., Joas S., Hotter D., et al. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 2014, 16:639-650.
23. Leulier F., Marchal C., Miletich I., Limbourg-Bouchon B., Benarous R., Lemaitre B. Directed expression of the HIV-1 accessory protein Vpu in Drosophila fat-body cells inhibits Toll-dependent immune responses. EMBO Rep. 2003, 4:976-981.
24. Lindwasser O.W., Chaudhuri R., Bonifacino J.S. Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr. Mol. Med. 2007, 7:171-184.
25. Liu R., Tan J., Lin Y., Jia R., Yang W., Liang C., Geng Y., Qiao W. HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β. Virology 2013, 439:47-56.
26. Mangeat B., Gers-Huber G., Lehmann M., Zufferey M., Luban J., Piguet V. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 2009, 5:e1000574.
27. Mangino G., Percario Z.A., Fiorucci G., Vaccari G., Acconcia F., Chiarabelli C., Leone S., Noto A., Horenkamp F.A., Manrique S., et al. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS ONE 2011, 6:e22982.
28. Mansur D.S., Maluquer de Motes C., Unterholzner L., Sumner R.P., Ferguson B.J., Ren H., Strnadova P., Bowie A.G., Smith G.L. Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog. 2013, 9:e1003183.
29. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., Benarous R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1998, 1:565-574.
30. Modi W.S., Goedert J.J., Strathdee S., Buchbinder S., Detels R., Donfield S., O'Brien S.J., Winkler C. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 2003, 17:2357-2365.
31. Napetschnig J., Wu H. Molecular basis of NF-κB signaling. Annu. Rev. Biophys. 2013, 42:443-468.
32. Neil S.J.D., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
33. Niederman T.M., Garcia J.V., Hastings W.R., Luria S., Ratner L. Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human Tcells. J.Virol. 1992, 66:6213-6219.
34. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
35. Parrish N.F., Gao F., Li H., Giorgi E.E., Barbian H.J., Parrish E.H., Zajic L., Iyer S.S., Decker J.M., Kumar A., et al. Phenotypic properties of transmitted founder HIV-1. Proc. Natl. Acad. Sci. USA 2013, 110:6626-6633.
36. Pfeffer L.M. The role of nuclear factor κB in the interferon response. J.Interferon Cytokine Res. 2011, 31:553-559.
37. Pickering S., Hué S., Kim E.-Y., Reddy S., Wolinsky S.M., Neil S.J.D. Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals. PLoS Pathog. 2014, 10:e1003895.
38. Promadej-Lanier N., Hanson D.L., Srinivasan P., Luo W., Adams D.R., Guenthner P.C., Butera S., Otten R.A., Kersh E.N. Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges. J.Acquir. Immune Defic. Syndr. 2010, 53:574-581.
39. Roux P., Alfieri C., Hrimech M., Cohen E.A., Tanner J.E. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J.Virol. 2000, 74:4658-4665.
40. Sauter D., Schindler M., Specht A., Landford W.N., Münch J., Kim K.-A., Votteler J., Schubert U., Bibollet-Ruche F., Keele B.F., et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421.
41. Sauter D., Unterweger D., Vogl M., Usmani S.M., Heigele A., Kluge S.F., Hermkes E., Moll M., Barker E., Peeters M., et al. Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog. 2012, 8:e1003093.
42. Schindler M., Münch J., Kutsch O., Li H., Santiago M.L., Bibollet-Ruche F., Müller-Trutwin M.C., Novembre F.J., Peeters M., Courgnaud V., et al. Nef-mediated suppression of Tcell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006, 125:1055-1067.
43. Schubert U., Schneider T., Henklein P., Hoffmann K., Berthold E., Hauser H., Pauli G., Porstmann T. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur. J. Biochem. 1992, 204:875-883.
44. Skasko M., Tokarev A., Chen C.-C., Fischer W.B., Pillai S.K., Guatelli J. BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology 2011, 411:65-77.
45. Tokarev A., Suarez M., Kwan W., Fitzpatrick K., Singh R., Guatelli J. Stimulation of NF-κB activity by the HIV restriction factor BST2. J.Virol. 2013, 87:2046-2057.
46. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
47. Van Lint C., Emiliani S., Ott M., Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 1996, 15:1112-1120.
48. Varin A., Decrion A.-Z., Sabbah E., Quivy V., Sire J., Van Lint C., Roques B.P., Aggarwal B.B., Herbein G. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J.Biol. Chem. 2005, 280:42557-42567.
49. Wang D., Westerheide S.D., Hanson J.L., Baldwin A.S. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J.Biol. Chem. 2000, 275:32592-32597.
50. Williams S.A., Chen L.-F., Kwon H., Ruiz-Jarabo C.M., Verdin E., Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 2006, 25:139-149.
51. Williams S.A., Kwon H., Chen L.-F., Greene W.C. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J.Virol. 2007, 81:6043-6056.
52. Yoon K., Kim S. Lack of negative influence on the cellular transcription factors NF-kappaB and AP-1 by the nef protein of human immunodeficiency virus type 1. J.Gen. Virol. 1999, 80:2951-2956.
53. Zhang F., Wilson S.J., Landford W.C., Virgen B., Gregory D., Johnson M.C., Munch J., Kirchhoff F., Bieniasz P.D., Hatziioannou T. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009, 6:54-67.